Rapidly Progressive Pulmonary Hypertension: Importance of Vascular Disease Distribution

Atsushi Tada; Ahmed U. Fayyaz; Yogesh N.V. Reddy; Margaret M. Redfield; Barry A. Borlaug

doi:10.1161/circulationaha.125.078277

Rapidly Progressive Pulmonary Hypertension: Importance of Vascular Disease Distribution

A Atsushi Tada (Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN.) A Ahmed U. Fayyaz (Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN.) Y Yogesh N.V. Reddy (Department of Cardiovascular Medicine (Y.N.V.R., R.P.F., W.R.M., R.V., B.A.B.), Mayo Clinic, Rochester, MN.) M Margaret M. Redfield (Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN.) B Barry A. Borlaug (From Baylor University Medical Center, Dallas (M.P.); Imperial College, London (M.P.); RHJ Department of Veterans Affairs, Health System and Medical University of South Carolina, Charleston (M.R.Z., S.E.L.); the Cardiovascular Division, Department of Medicine, University of Virginia Health System, Charlottesville (C.M.K.); Flourish Research, Boca Raton, FL (S.J.B.); the Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland (V.M.); the Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, China (J.G.); Eli Lilly, Indianapolis (G.J.W., Y.O., M.C.B., K.C.H., M.M.); and the Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN (B.A.B.).)

View Original

APA MLA Chicago BibTeX RIS

Article Details

Journal Circulation

Volume / Issue Vol. 153, Issue 4

Published January 27, 2026

Pages 285-289

DOI 10.1161/circulationaha.125.078277

ISSN 0009-7322

Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (5)

A

Atsushi Tada

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN.

A

Ahmed U. Fayyaz

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN.

Y

Yogesh N.V. Reddy

Department of Cardiovascular Medicine (Y.N.V.R., R.P.F., W.R.M., R.V., B.A.B.), Mayo Clinic, Rochester, MN.

M

Margaret M. Redfield

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN.

B

Barry A. Borlaug

From Baylor University Medical Center, Dallas (M.P.); Imperial College, London (M.P.); RHJ Department of Veterans Affairs, Health System and Medical University of South Carolina, Charleston (M.R.Z., S.E.L.); the Cardiovascular Division, Department of Medicine, University of Virginia Health System, Charlottesville (C.M.K.); Flourish Research, Boca Raton, FL (S.J.B.); the Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland (V.M.); the Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, China (J.G.); Eli Lilly, Indianapolis (G.J.W., Y.O., M.C.B., K.C.H., M.M.); and the Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN (B.A.B.).

Rapidly Progressive Pulmonary Hypertension: Importance of Vascular Disease Distribution

Article Details

Journal Info

Authors (5)

Related Articles from this Journal

Occupational Radiation Safety in Electrophysiology During Pregnancy: Evaluating Uterine Radiation Doses During Catheter Ablations and Device Implantations

Response by Rogers et al to Letter Regarding, “Deep Learning-Based Continuous QT Monitoring to Identify High-Risk Prolongation Events After Class III Antiarrhythmic Initiation”

Clinical Cardiology at the Crossroads: Perspectives on the Next Era at <i>Circulation</i>

ABHD11-Mediated mtDNA Transcription Restored Mitochondrial Function to Attenuate Cardiomyocyte Ferroptosis After Myocardial Infarction

Letter by Li et al Regarding Article, “Deep Learning-Based Continuous QT Monitoring to Identify High-Risk Prolongation Events After Class III Antiarrhythmic Initiation”